| Phlebotonics for venous insufficiency MJ Martinez‐Zapata, XB Cosp, RM Moreno, E Vargas, D Capellà Cochrane Database of Systematic Reviews, 2005 | 443 | 2005 |
| Phlebotonics for venous insufficiency MJ Martinez‐Zapata, XB Cosp, RM Moreno, E Vargas, D Capellà Cochrane Database of Systematic Reviews, 2005 | 443 | 2005 |
| Descriptive tools and analysis D Capellà WHO regional publications european series, 55-55, 1993 | 226 | 1993 |
| Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life J Fiz, M Durán, D Capellà, J Carbonell, M Farré PloS one 6 (4), e18440, 2011 | 199 | 2011 |
| Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting M Duran, E Pérez, S Abanades, X Vidal, C Saura, M Majem, E Arriola, ... British journal of clinical pharmacology 70 (5), 656-663, 2010 | 198 | 2010 |
| Drug utilization studies: a tool for determining the effectiveness of drug use. JR Laporte, M Porta, D Capella British journal of clinical pharmacology 16 (3), 301-304, 1983 | 168 | 1983 |
| Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer’s disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16 … L Blanco-Silvente, X Castells, M Saez, MA Barceló, J Garre-Olmo, ... International Journal of Neuropsychopharmacology 20 (7), 519-528, 2017 | 148 | 2017 |
| Efficacy of psychostimulant drugs for cocaine dependence X Castells, M Casas, C Pérez‐Mañá, C Roncero, X Vidal, D Capella Cochrane Database of Systematic Reviews, 2010 | 142 | 2010 |
| Métodos aplicados en estudios descriptivos de utilización de medicamentos D Capellà, JR Laporte Principios de epidemiología del medicamento 2, 67-93, 1993 | 141 | 1993 |
| Psychostimulant drugs for cocaine dependence X Castells, R Cunill, C Pérez‐Mañá, X Vidal, D Capellà Cochrane Database of Systematic Reviews, 2016 | 132 | 2016 |
| Efficacy of psychostimulant drugs for amphetamine abuse or dependence C Pérez‐Mañá, X Castells, M Torrens, D Capellà, M Farre Cochrane Database of Systematic Reviews, 2013 | 126 | 2013 |
| Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence R Cunill, X Castells, A Tobias, D Capellà Journal of psychopharmacology 29 (1), 15-23, 2015 | 111 | 2015 |
| Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients R Cunill, X Castells, A Tobias, D Capellà Psychopharmacology 233, 187-197, 2016 | 97 | 2016 |
| Bovine gangliosides and acute motor polyneuropathy. A Figueras, FJ Morales-Olivas, D Capella, V Palop, JR Laporte BMJ: British Medical Journal 305 (6865), 1330, 1992 | 95 | 1992 |
| Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta‐analysis of randomized controlled clinical trials X Castells, M Casas, X Vidal, R Bosch, C Roncero, JA Ramos‐Quiroga, ... Addiction 102 (12), 1871-1887, 2007 | 93 | 2007 |
| Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs: a report from the Spanish System of Pharmacovigilance, including an early analysis of … A Figueras, D Capella, JM Castel, JR Laporte European journal of clinical pharmacology 47, 297-303, 1994 | 91 | 1994 |
| Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta‐analysis and meta‐regression R Cunill, X Castells, A Tobias, D Capellà Pharmacoepidemiology and drug safety 22 (9), 961-969, 2013 | 87 | 2013 |
| Mecanismos de producción y diagnóstico clínico de los efectos indeseables producidos por medicamentos JR Laporte, D Capellà Principios de epidemiología del medicamento 2, 1993 | 81 | 1993 |
| La notificación espontánea de reacciones adversas a medicamentos D Capellà, JR Laporte Principios de epidemiología del medicamento. Barcelona: Masson-Salvat, 147-70, 1993 | 80 | 1993 |
| Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads JM Castel, A Figueras, C Pedrós, JR Laporte, D Capella Drug safety 26, 1049-1055, 2003 | 76 | 2003 |
